Agricultural products company Advanced Enzyme Technologies' share price rallied 16 percent after Nalanda India Equity Fund bought 3.75 percent equity stake via open market transaction on September 24. The stock gained as much as 16 percent and went up to Rs 317 a piece on the NSE. At 1.50 pm on September 25, the shares traded over 9 percent at Rs 298.55.
According to the bulk deal data, Nalanda India Equity Fund bought 41,90,491 equity shares in Advanced Enzyme Technologies (representing 3.75 percent of the total paid-up equity) at Rs 263.8 per share.
In the last two days, the stock zoomed by 41.5 percent. Since March low levels, the stock has delivered 220 percent returns to shareholders.
Advanced Enzymes is a research-driven company with global leadership in the manufacturing of enzymes and probiotics.
In its annual report 2019-20, the company mentioned that it expects to benefit from the healthcare spending in the US. The demand of probiotics and genetically modified proteins is picking up, which will be a trigger for revenue generation.
The company's management is looking to expand its distribution channels in North America, Latin America and Europe and drive more revenues.
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Odisha Lok Sabha elections: Schedule, total seats, Congress candidates and more
Apr 20, 2024 11:39 AM
Lok Sabha Election 2024: Issues raised by Prime Minister Modi have not resonated with people of Tamil Nadu, says Congress
Apr 19, 2024 11:38 PM
West Bengal Lok Sabha elections 2024: A look at Congress candidates
Apr 19, 2024 8:45 PM